Skip to main content

Doc J Thurston Distinguished Professor of Medicine
Chief, Division of Nephrology and Hypertension

Specialty Areas

Acute and chronic kidney disease; Fluid, electrolyte, and acid-base disturbances; Medical education.

Education and Experience

BA Summa Cum Laude with Distinction in Biology: Boston University, 1985; MD Magna Cum Laude: Boston University, 1989; Internal Medicine Resident: University of North Carolina, 1989-92; Clinical Instructor in Medicine: University of North Carolina, 1992-4; Nephrology Fellow: University of North Carolina, 1994-6; Clinical Assistant Professor of Medicine: University of North Carolina, 1996-2003; Clinical Associate Professor of Medicine: 2003-2009; Clinical Professor of Medicine: 2009-Present; Medical Director: UNC Hospitals Acute Dialysis Program, 1996-Present; Medical Director: Carolina Dialysis-Carrboro, 1996-2009; Course Director: Urinary System Course, 1998-2015; Nephrology (Internal Medicine) Training Program Director: 2009-Present; Interim Chief: Division of Nephrology and Hypertension, 2015-2016; Chief: Division of Nephrology and Hypertension, November 2016-present.

Clinical and Research Interests

Dr. Hladik’s clinical interests include the evaluation of acute and chronic kidney disease, the diagnosis and management of complex electrolyte disorders, and geriatric nephrology. His academic mission is to improve education in nephrology spanning from foundational training in kidney physiology and nephrology during medical school, residency, and fellowship, through continuing education for practicing nephrologists. He currently is Education Director for Maintenance of Certification for the American Society of Nephrology (ASN). In this role, he serves as co-editor for the Nephrology Self-Assessment Program(NephSAP), the premier continuing education program for ASN.

Selected Bibliography

Hladik GA. Co-editor , along with Yee J, for the Nephrology Self-Assessment Program, published by the American Society of Nephrology; Chronic Kidney Disease and Progression, September 2013; Transplantation, November 2013; Vaso-Occlusive Disorders and Kidney Disease, January 2014; Hypertension, March 2014; Disorders of Divalent Ions, Renal Bone Disease, and Nephrolithiasis, July 2014; Glomerular, Vascular, and Tubulointerstitial Disorders, September, 2014. End-Stage Renal Disease and Dialysis, November 2014. Fluid, Electrolytes, and Acid-Base Disturbances,March 2015.Acute Kidney Injury and Critical Care Nephrology, July 2015. Cystic Diseases and the Kidney, September, 2015. Chronic Kidney Disease and Progression, October, 2015. Transplantation, November 2015.NephSAPis considered the premier maintenance of certification publication for practicing nephrologists in the US.

Hladik GA. Co-editor and co-creator, along with Hoenig MP, of the Kidney Self-Assessment Program,American Society of Nephrology, anticipated publication of first edition Spring 2014. This is a new MOC tool for practicing nephrologists and Board Eligible Nephrologists to help prepare for the secure ABIM Board Certification examination.

Song MK, Ward SE, Fine JP, Hanson LC, Lin FC, Hladik GA, Hamilton JB, Bridgman JC. Advance Care Planning and End-of-Life Decision Making in Dialysis: A Randomized Controlled Trial Targeting Patients and Their Surrogates. Am J Kidney Dis2015 Jun 30 [Epub ahead of print].

Bleyer AJ, Kmoch S, Antignac C, Robins V, Kidd K, Kelsoe JR, Hladik G, Klemmer P, Knohl SJ, Scheinman SJ, Vo N, Santi A, Harris A, Canaday O, Weller N, Hulick PJ, Vogel K, Rahbari-Oskoui FF, Tuazon J, Deltas C, Somers D, Megarbane A, Kimmel PL, Sperati CJ, Orr-Urtreger A, Ben-Shachar S, Waugh DA, McGinn S, Bleyer AJ Jr, Hodanová K, Vylet’al P, Živná M, Hart TC, Hart PS. Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1. Clin J Am Soc Nephrol9: 527-535, 2014.

Song MK, Hanson LC, Gilet CA, Jo M, Reed TJ, Hladik GA. Management of Ethical Issues Related to Care of Seriously Ill Dialysis Patients in Free-Standing Facilities. J Pain Symptom Manage48: 343-352, 2014.

Hoenig MP, Shapiro E, Hladik GE. Lessons learned from the ASN Renal Educator Listserv and survey. Clin J Am Soc Nephrol 8(6):1054-1060, 2013.

Song MK, Ward SE, Hanson LC, Lin FC, Hamilton JB, Hladik G, Fine JP, Bridgman JC, Sun SK, Miles MS. Psychological Symptoms and End-of-Life Decision-Making Confidence in Surrogate Decision Makers of Dialysis Patients. J Neph SW 37: 24-30, 2012.

Hladik GA. Book editor for Nephrology Section of Medical Knowledge and Self-Assessment Program (MKSAP) 16, Philadelphia, Pa: American College of Physicians, 2012.

Hladik GA. Fluid, Electrolyte, and Acid-Base Disorders. Medical Knowledge and Self-Assessment Program 16, Philadelphia, Pa: American College of Physicians, 2012

Hladik GA. Acute Kidney Injury and Chronic Kidney Disease in Medical Knowledge and Self-Assessment Program 15, Philadelphia, Pa: American College of Physicians, 2009.

Hladik GA: Chronic kidney disease. In Netter’s Internal Medicine, 2nd ed., Runge MA and Greganti MA, ed. Philadelphia, Pa: Elsevier; 975-983, 2007.

Hladik GA. Acute Renal Failure in Medical Knowledge and Self-Assessment Program 14, Philadelphia, Pa: American College of Physicians, 39-48, 2006.

Joy MS and Hladik GA: Disorders of sodium, water, calcium, and phosphorus. In Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG and Posey LM, ed. Pharmacotherpy: A pathophysiologic approach, 5th ed. New York: McGraw Hill, 953-980, 2002.

Joy MS, Denu-Ciocca C, Phillips T, Hogan SL and Hladik GA: Lipids in chronic hemodialysis patients: demographic differences and associations with albumin and homocysteine. J Am Soc Nephrol 10: 245A, 1999.

Finn WF, Joy MS, Hladik GA, and the Lanthanum Study Group: Results of a randomized dose-ranging, placebo controlled study of lanthanum carbonate for reduction of serum phosphate in chronic renal failure patients receiving hemodialysis. J Am Soc Nephrol 10: 261A, 1999.

Finn WF, Joy MS, Hladik GA, and the Lanthanum Study Group: Safety of an investigational phosphate binder (lanthanum carbonate) in hemodialysis patients. J Am Soc Nephrol 10: 231A, 1999.

Goodman WG, Hladik GA, Turner SA, Blaisdell PW, Goodkin DA, Liu W, Yoursi BM, Cohen RM and Coburn JW: The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 13: 1017-1024, 2002.

Tawney KW, Tawney PJW, Hladik GA, Hogan SL, Moore DT, and Falk RJ: The Life Readiness Program: a rehabilitation program for end-stage renal disease patients on hemodialysis. J Am Soc Nephrol 10: 270A, 1999.

View list of publications on PubMed.